PGD for hereditary breast and ovarian cancer: the route to universal tests for BRCA1 and BRCA2 mutation carriers

Preimplantation Genetic Diagnosis (PGD) is a method of testing in vitro embryos as an alternative to prenatal diagnosis with possible termination of pregnancy in case of an affected child. Recently, PGD for hereditary breast and ovarian cancer caused by BRCA1 and BRCA2 mutations has found its way in...

詳細記述

保存先:
書誌詳細
主要な著者: Drüsedau, Marion, Dreesen, Jos C, Derks-Smeets, Inge, Coonen, Edith, van Golde, Ron, van Echten-Arends, Jannie, Kastrop, Peter M M, Blok, Marinus J, Gómez-García, Encarna, Geraedts, Joep P, Smeets, Hubert J, de Die-Smulders, Christine E, Paulussen, Aimée D
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2013
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3831069/
https://ncbi.nlm.nih.gov/pubmed/23531862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ejhg.2013.50
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料